| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","article_chars":1521,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4c9e3208203e3c88","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:23:06.601812+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt","source_event_id":"evt_74e286640df1","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"7a00a6b997eff694","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-17","2025-12-18","1999-03-24"],"entities":[{"asset_class":"equity","name":"UNITED THERAPEUTICS Corp","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Christopher Patusky","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Morgan Stanley Smith Barney LLC","relevance":"medium","symbol":"","type":"broker"}],"event_type":"listing","information_gaps":["The text does not explicitly state the number of shares to be sold/disposed, the exact security class beyond \u201cCommon,\u201d or whether the transaction is a sale vs other disposition beyond the presence of \u201cStock Option Exercise.\u201d","No prior known state is provided in the prompt, so the \u201cwhat changed vs prior known state\u201d cannot be determined from the supplied text alone.","The filing\u2019s detailed table fields (e.g., share count, aggregate sale price, remaining shares) are not fully interpretable from the cleaned excerpt provided."],"key_facts":["SEC accession number: 0001950047-26-003588.","Conformed submission type: Form 144.","Filed as of date and date as of change: 2026-04-17.","Subject company: UNITED THERAPEUTICS Corp (CIK 0001082554).","Reporting-owner name: Christopher Patusky (CIK 0001231427).","Business address for issuer: 1000 Spring St, Silver Spring, MD 20910.","Filing values include: form type 144; SEC Act: 1933 Act; SEC file number: 000-26301.","Transaction-related fields shown include: \u201cStock Option Exercise\u201d and \u201cCash Y\u201d.","A numeric value shown: 578880.00.","Another numeric value shown: 43827686.","Dates shown include: 04/17/2026 and 12/18/2025.","Signature line shows: /s/ Christopher Patusky."],"numeric_claims":[{"label":"numeric_value_1","value":"578880.00"},{"label":"numeric_value_2","value":"43827686"}],"primary_claim":"On 2026-04-17, UNITED THERAPEUTICS Corp filed SEC Form 144 (accession 0001950047-26-003588).","relevance_score":0.35,"sentiment":"neutral","source_quality":"medium","summary":"United Therapeutics Corp filed a Form 144 on 2026-04-17. The filing indicates a director (Christopher Patusky) and includes details consistent with a common stock transaction tied to an option exercise.","topics":["SEC Form 144","insider/director sale/disposition","common stock","option exercise","United Therapeutics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260417","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 144","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001950047-26-003588.txt"}... |